These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

52 related items for PubMed ID: 1764544

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Formation of neutralizing antibodies after treatment with human calcitonin.
    Grauer A, Reinel HH, Lunghall S, Lindh E, Ziegler R, Raue F.
    Am J Med; 1993 Oct; 95(4):439-42. PubMed ID: 8213878
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of postmenopausal and senile osteoporosis with synthetic salmon calcitonin. A clinical study].
    Salvini S, Nicolazzo F, Farina P, Martelli G.
    Clin Ter; 1987 Jun 30; 121(6):471-7. PubMed ID: 2973883
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of osteoporosis with calcitonin.
    Wallach S, Aloia J, Cohn S.
    Semin Drug Treat; 1972 Jun 30; 2(1):21-5. PubMed ID: 5065516
    [No Abstract] [Full Text] [Related]

  • 7. [Current treatment concepts in primary osteoporosis: calcitonin].
    Ringe JD.
    Schweiz Med Wochenschr; 1993 Nov 27; 123(47):2235-40. PubMed ID: 8272794
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Development and characterization of a competitive polyclonal antibody enzyme-immunoassay for salmon insulin-like growth factor-II.
    Wilkinson RJ, Elliott P, Hohmann A, Francis G, Carragher J.
    Comp Biochem Physiol B Biochem Mol Biol; 2004 Oct 27; 139(2):193-201. PubMed ID: 15465665
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Profile of a new calcitonin: carbocalcitonin-(Asu1,7) E-CT].
    Nogarin L, Passarella E.
    Minerva Med; 1984 Jul 31; 75(30-31):1809-18. PubMed ID: 6207466
    [Abstract] [Full Text] [Related]

  • 16. Observations on an enzyme-linked immunosorbent assay for the detection of antibodies against avian leukosis-sarcoma viruses.
    Smith EJ, Fadly AM, Crittenden LB.
    Avian Dis; 1986 Jul 31; 30(3):488-93. PubMed ID: 3021098
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of calcitonin in the prevention of experimental osteoporosis.
    Carrozzo M, Pallante R, Cantatore FP, Lo Sasso F, Pipitone V.
    Panminerva Med; 1984 Jul 31; 26(4):267-72. PubMed ID: 6533551
    [No Abstract] [Full Text] [Related]

  • 18. [Evaluation of osteoclastic activity in multiple myeloma: results of a randomized trial studying hypocalcemia induced by human and salmon calcitonin in 49 patients].
    Fuzibet JG, Lejeune C, Lepeu G, Jaubert J, Sotto JJ, Peyron R.
    Rev Rhum Mal Osteoartic; 1991 Mar 31; 58(3):223-7. PubMed ID: 2057701
    [Abstract] [Full Text] [Related]

  • 19. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 9. Calcitonin in the treatment of osteoporosis.
    Siminoski K, Josse RG.
    CMAJ; 1996 Oct 01; 155(7):962-5. PubMed ID: 8837547
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.